Index of medicine substances

Paracetamol + pseudoephedrine + dextromethorphan

Indicated for: cold and flu symptoms

R05DA20 Respiratory system | Cough suppressants, excl. combinations with expectorants | Opium alkaloids and derivatives

Paracetamol + pseudoephedrine + dextromethorphan + chlorpheniramine

Indicated for: cold and flu symptoms

R05DA20 Respiratory system | Cough suppressants, excl. combinations with expectorants | Opium alkaloids and derivatives

Parathyroid hormone

Indicated for: hypoparathyroidism

H05AA03 Systemic hormonal preparations, excluding sex hormones and insulins | Parathyroid hormones and analogues

Parecoxib

Indicated for: pain and inflammation

M01AH04 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Coxibs

Paricalcitol

Indicated for: hyperparathyroidism

H05BX02 Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents

Paroxetine

Indicated for: depression; anxiety disorders

N06AB05 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors

Pasireotide

Indicated for: Cushing disease; acromegaly

H01CB05 Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues

Passion flower herb extract

Indicated for: mild restlessness; minor sleep disorders

Passionflower

Indicated for: mild restlessness; minor sleep disorders

N05CMN1 Nervous system | Hypnotics and sedatives | Other hypnotics and sedatives

Patiromer calcium

Indicated for: hyperkalaemia

V03AE09 Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia

Patisiran

Indicated for: transthyretin amyloidosis

N07XX12 Nervous system | Other nervous system drugs | Other nervous system drugs

Pazopanib

Indicated for: cancer

L01EX03 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Pefloxacin

Indicated for: bacterial infections

J01MA03 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones

Pegaptanib sodium

Indicated for: macular degeneration; diabetic macular edema

S01LA03 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents

Pegaspargase

Indicated for: cancer

L01XX24 Antineoplastic and immunomodulating agents | Other antineoplastic agents

Pegcetacoplan

Indicated for: complement-mediated disorders

L04AJ03 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Complement inhibitors

Pegfilgrastim

Indicated for: neutropenia

L03AA13 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Colony stimulating factors

Peginterferon alfa 2B

Indicated for: viral infections; multiple sclerosis; cancer

L03AB10 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons

Peginterferon alfa-2A

Indicated for: viral infections; multiple sclerosis; cancer

L03AB11 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons

Peginterferon beta-1A

Indicated for: multiple sclerosis

L03AB13 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons

Pegunigalsidase alfa

Indicated for: lysosomal enzyme deficiency

A16AB20 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Pegvisomant

Indicated for: acromegaly

H01AX01 Systemic hormonal preparations, excluding sex hormones and insulins | Anterior pituitary lobe hormones and analogues | Other anterior pituitary lobe hormones and analogues

Pelargonium root extract

Indicated for: common cold; acute bronchitis

R07AXN5 Respiratory system | Other respiratory system products | Other respiratory system products

Pembrolizumab

Indicated for: cancer

L01FF02 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Pemetrexeda

Indicated for: non-small cell lung cancer

L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues

Pemigatinib

Indicated for: cancer

L01EX20 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Penicillamine

Indicated for: Wilson disease

M01CC01 Musculo-skeletal system | Specific antirheumatic agents | Penicillamine and similar agents

Pentaerythrityl tetranitrate

Indicated for: angina pectoris

C01DA05 Cardiovascular system | Vasodilators used in cardiac diseases | Organic nitrates

Pentazocine

Indicated for: moderate to severe pain

N02AD01 Nervous system | Opioids | Benzomorphan derivatives

Pentoxifylline

Indicated for: peripheral vascular disease; circulatory disorders

C04AD03 Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Purine derivatives